Kassandra Allbright (@kassandraallbr1) 's Twitter Profile
Kassandra Allbright

@kassandraallbr1

The luckiest co-parent. Current fellow @paccm. @OslerResidency alum, but Janeway Firm forever.

ID: 1080406668591198208

calendar_today02-01-2019 10:13:17

63 Tweet

300 Followers

482 Following

Pitt PACCSM Fellows (@paccsm_fellows) 's Twitter Profile Photo

PACCM Fellows showing up strong at #PILC2022! It is so nice to be back in-person for amazing networking opportunities like this! #ThisIsPACCM #MedTwitter #PULMTwitter PittDeptofMed UPMC

<a href="/PACCM/">PACCM</a> Fellows showing up strong at #PILC2022! It is so nice to be back in-person for amazing networking opportunities like this!

#ThisIsPACCM #MedTwitter #PULMTwitter <a href="/PittDeptofMed/">PittDeptofMed</a> <a href="/UPMCnews/">UPMC</a>
Oliver (@eickelberg_md) 's Twitter Profile Photo

What a beautiful venue for our 2023 Melanie Königshoff Oliver lab retreat: The Schenley Park Cafe in Pittsburgh, PA. Great weather, superb science, fantastic people and good coffee, nothing more to ask for. Looking very forward to 2 days of discussions! Pittsburgh Parks Conservancy

What a beautiful venue for our 2023 <a href="/m_konigshoff/">Melanie Königshoff</a> <a href="/Eickelberg_MD/">Oliver</a> lab retreat: The Schenley Park Cafe in Pittsburgh, PA. Great weather, superb science, fantastic people and good coffee, nothing more to ask for. Looking very forward to 2 days of discussions! <a href="/pittsburghparks/">Pittsburgh Parks Conservancy</a>
Amanda Moale (@amandamoale) 's Twitter Profile Photo

Wonderful morning presenting alongside colleagues improving family and patient needs across the critical care continuum and thankful for the ongoing support of my co-fellows and mentors: Judy Chang, Bryan McVerry Bryan McVerry and Leslie Scheunemann Leslie Scheunemann, MD MPH #ATS2023 PACCSM

Wonderful morning presenting alongside colleagues improving family and patient needs across the critical care continuum and thankful for the ongoing support of my co-fellows and mentors: Judy Chang, Bryan McVerry <a href="/B_McVerry/">Bryan McVerry</a> and Leslie Scheunemann <a href="/lpscheun/">Leslie Scheunemann, MD MPH</a> #ATS2023 <a href="/PACCSM/">PACCSM</a>
Hopkins Pulmonary and Critical Care Medicine (@hopkinspccm) 's Twitter Profile Photo

Ain't no party like a HopkinsPCCM party #ATS2023 One of the best parts of every #ATS is seeing the generations of trainees and faculty that make Hopkins PCCM a true family ❤️

Ain't no party like a HopkinsPCCM party #ATS2023 

One of the best parts of every #ATS is seeing the generations of trainees and faculty that make Hopkins PCCM a true family ❤️
Kathryn Hibbert (@khibbert_md) 's Twitter Profile Photo

.@iwashyna spoke with this morning with sincerity & conviction about what’s at stake w/conference site selection. We look forward to more conversations with American Thoracic Society (ATS) about how to keep our members and their families safe and our society strong #ATS2023 #ATSSafe4All

.@iwashyna spoke with this morning with sincerity &amp; conviction about what’s at stake w/conference site selection. We look forward to more conversations with <a href="/atscommunity/">American Thoracic Society (ATS)</a> about how to keep our members and their families safe and our society strong #ATS2023 #ATSSafe4All
PittDeptofMed (@pittdeptofmed) 's Twitter Profile Photo

Congratulations to Dr. Corrine Kliment on her new @nih_nhlbi R01: "The Role of Adenine Nucleotide Translocase in Mitochondrial Dysfunction Associated Senescence in Chronic Obstructive Pulmonary Disease (COPD)!"🎉🎊🎉 #ThisIsPACCSM

Congratulations to Dr. Corrine Kliment on her new @nih_nhlbi R01: "The Role of Adenine Nucleotide Translocase in Mitochondrial Dysfunction Associated Senescence in Chronic Obstructive Pulmonary Disease (COPD)!"🎉🎊🎉
#ThisIsPACCSM
ERS publications (@erspublications) 's Twitter Profile Photo

A real-world study supports the new 2023 GOLD recommendation that single-inhaler triple therapy be reserved for group E and other exacerbating COPD patients with blood eosinophils count >300, otherwise it is not more effective and is riskier than LAMA-LABA bit.ly/3NpWtZC

A real-world study supports the new 2023 GOLD recommendation that single-inhaler triple therapy be reserved for group E and other exacerbating COPD patients with blood eosinophils count &gt;300, otherwise it is not more effective and is riskier than LAMA-LABA bit.ly/3NpWtZC